Complement factor h polymorphism in age-related maculopathy in the chinese population: The Beijing Eye Study

Retina

Volumn 30, Issue 3, 2010, Pages 443-446

  Gao, Ya ^a   Li, Yibin ^a   Xu, Liang ^a   Li, Yang ^a   Zhang, Hai Tao ^a   Jonas, Jost B ^b   Sun, Bao Chen ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Age related maculopathy; Beijing Eye Study; Complement factor H polymorphism; Genetics

Indexed keywords

COMPLEMENT FACTOR H;

ADULT; AGE RELATED MACULOPATHY; ARTICLE; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; DRUSEN; EYE EXAMINATION; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPY; POLYMERASE CHAIN REACTION; RETINA MACULOPATHY; RURAL AREA; URBAN AREA;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; COMPLEMENT FACTOR H; FEMALE; GENOTYPE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RETINAL DRUSEN; VISUAL ACUITY;

EID: 77949358888     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181c2e086     Document Type: Article

References (28)

1. Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991;98:1128-1134.
2. Bird AC, Bressler NM, Bressler SB, et al., An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995;39:367-374.
3. Arnarsson A, Sverrisson T, Stefánsson E, et al., Risk factors for five-year incident age-related macular degeneration: the Reykjavik Eye Study. Am J Ophthalmol 2006;142:419-428.
4. Van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, De Jong PT. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. Arch Ophthalmol 2003;121:519-526.
5. Holz FG, Wolfensberger TJ, Piguet B, et al., Bilateral macular drusen in age-related macular degeneration: prognosis and risk factors. Ophthalmology 1994;101:1522-1528.
6. Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of age-related macular degeneration. Am J Ophthalmol 2004; 137:486-495.
7. Moshfeghi DM, Blumenkranz MS. Role of genetic factors and inflammation in age-related macular degeneration. Retina 2007;27:269-275.
8. Klein RJ, Zeiss C, Chew EY, et al., Complement factor H polymorphism in age-related macular degeneration. Science 2005;308:385-389.
9. Edwards AO, Ritter R III, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and agerelated macular degeneration. Science 2005;308:421-424.
10. Haines JL, Hauser MA, Schmidt S, et al., Complement factor H variant increases the risk of age-related macular degeneration. Science 2005;308:419-421.
11. Magnusson KP, Duan S, Sigurdsson H, et al., CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLoS Med 2006;3:e5.
12. Souied EH, Leveziel N, Richard F, et al., Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population. Mol Vis 2005; 11:1135-1140.
13. Lau LI, Chen SJ, Cheng CY, et al., Association of the Y402H polymorphism in complement factor H gene and neovascular age-related macular degeneration in Chinese patients. Invest Ophthalmol Vis Sci 2006;47:3242-3246.
14. Kim NR, Kang JH, Kwon OW, Lee SJ, Oh JH, Chin HS. Association between complement factor H gene polymorphisms and neovascular age-related macular degeneration in Koreans. Invest Ophthalmol Vis Sci 2008;49:2071-2076.
15. Kaur I, Hussain A, Hussain N, et al., Analysis of CFH, TLR4, and APOE polymorphism in India suggests the Tyr402His variant of CFH to be a global marker for age-related macular degeneration. Invest Ophthalmol Vis Sci 2006;47:3729-3735.
16. Li Y, Xu L, Jonas JB, Yang H, Ma Y, Li J. Prevalence of age-related maculopathy in the adult population in China: the Beijing Eye Study. Am J Ophthalmol 2006;142:788-793.
17. Sommer A, Tielsch JM, Katz J, et al., Racial differences in the cause-specific prevalence of blindness in east Baltimore. N Engl J Med 1991;325:1412-1417.
18. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia: the Blue Mountains Eye Study. Ophthalmology 1995;102:1450-1460.
19. Klaver CC, Wolfs RC, Vingerling JR, Hofman A, De Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 1998;116:653-658.
20. Klein R, Klein BE, Cruickshanks KJ. The prevalence of agerelated maculopathy by geographic region and ethnicity. Prog Retin Eye Res 1999;18:371-389.
21. Schachat AP, Hyman L, Leske MC, Connell AM, Wu SY. Features of age-related macular degeneration in a black population: the Barbados Eye Study Group. Arch Ophthalmol 1995;113:728-735.
22. Dineen BP, Bourne RR, Ali SM, Huq DM, Johnson GJ. Prevalence and causes of blindness and visual impairment in Bangladeshi adults: results of the National Blindness and Low Vision Survey of Bangladesh. Br J Ophthalmol 2003;87:820-828.
23. Thulasiraj RD, Nirmalan PK, Ramakrishnan R, et al., Blindness and vision impairment in a rural south Indian population: the Aravind Comprehensive Eye Survey. Ophthalmology 2003;110:1491-1498.
24. Lim JI, Kwok A, Wilson DK. Symptomatic age-related macular degeneration in Asian patients. Retina 1998;18:435-438.
25. Chang TS, Hay D, Courtright P. Age-related macular degeneration in Chinese-Canadians. Can J Ophthalmol 1999;34: 266-271.
26. Tsai SY, Hsu WM, Cheng CY, Liu JH, Chou P. Epidemiologic study of age-related cataracts among an elderly Chinese population in Shih-Pai, Taiwan. Ophthalmology 2003;110:1089-1095.
27. Saw SM, Foster PJ, Gazzard G, Seah S. Causes of blindness, low vision, and questionnaire-assessed poor visual function in Singaporean Chinese adults: the Tanjong Pagar Survey. Ophthalmology 2004;111:1161-1168.
28. Hsu WM, Cheng CY, Liu JH, Tsai SY, Chou P. Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology 2004; 111:62-69.